Genmab raises 2016 guidance on strong Darzalex sales
April 20, 2016 at 01:26 AM EDT
COPENHAGEN, April 20 (Reuters) - Danish biotech company Genmab raised its financial guidance for 2016 on Wednesday due to "robust" sales of its blood cancer drug Darzalex since it was launched in November.
